download
PDF
|
Ovarian steroid cell tumor, not otherwise specified
Abstract
Ovarian steroid cell tumours are rare virilizing tumours. They are three types of tumours of ovary which are characterized by steroid cell proliferation : Leydig cell tumour, steroid cell tumour, Not Otherwise Specified (NOS) and stromal luteoma. Here we present a case of 36 year old female, who presented with history of weight loss since last two and half months. There is history of amenorrhoea and hirsuitism. Her CA was 125: 11.4 IU/ml (0-35 U/mL). Blood Testosterone levels was elevated with value of 150 ng/ml (5.71-77 ng/ml). Serum Inhibin A, Inhibin B, FSH, LH and prolactin were within normal limits. The steroid cell tumour, NOS are mostly benign but few of them behave in malignant fashion. Hayes and Scully gave few histopathological features which favour malignant behavior. These tumours should be differentiated from leydig cell tumour by lack of cytoplasmic Reinkes’ crystals as well as from other neoplasms like primary clear cell carcinoma, metastatic clear cell renal cell carcinoma and adrenocortical tumour.
Full text
Dear Editor-in-Chief,
Ovarian steroid cell tumours are rare virilizing tumours accounting for less than 0.1% of all tumours of the ovary. They are three types of tumours of ovary which are characterized by steroid cell proliferation : Leydig cell tumour, steroid cell tumour, Not Otherwise Specified (NOS) and stromal luteoma 1 2. Out of these tumours, steroid cell tumour (NOS) is the most common accounting for approximately 60% of these tumours 3. Steroid cell tumour, NOS are mostly unilateral and majority of them present with virilization. The age of presentation ranges from two and half years to eighty years 1.
Here we present a case of 36 year old female, who presented with history of weight loss since last two and half months. There is history of amenorrhoea and hirsuitism. Her CA was 125: 11.4 IU/ml (0-35 U/mL). Blood Testosterone levels was elevated with value of 150 ng/ml (5.71-77 ng/ml). Serum Inhibin A, Inhibin B, FSH, LH and prolactin were within normal limits. MRI (Magnetic Resonance Imaging) whole abdomen with contrast was done and showed a large, oval, solid heterogenous enhancing mass lesion in right adnexa (Fig. 1A). This Mass showed heterogenous enhancement on post contrast study suggestive of right mitotic ovarian lesion (Fig. 1B). After the radiological examination, r ight salphingo-oopherectomy with infracolic omentectomy was done. The specimen of right ovary showed a well-circumscribed yellow colored tumour measuring mm. The histopathological examination showed a well circumscribed neoplasm composed of sheets of polygonal cells (Fig. 1C). The cells had clear to pale eosinophilic cytoplasm (Fig. 1 D). The nuclei were small and round with mild atypia . Mitosis was infrequent. No Reinkes’ crystals identified. There was no necrosis and haemorrhage (Fig. 1E, F). The patient is under follow- up since past one year. The testosterone level dropped significantl post-surgery and now is within normal limits.
The steroid cell tumour, NOS are mostly benign but few of them behave in malignant fashion. Hayes and Scully gave few histopathological features which favour malignant behavior. These are two or more mitotic figures per high power fields, grade 2-3 nuclear atypia, necrosis, haemorrhage and size of the tumor more than seven centimeters 2.
The management of these tumours is surgery and follow-up monitoring of testosterone levels specially in those patients who demonstrate elevated levels before the surgical removal of ovarian tumour 4. These tumours should be differentiated from leydig cell tumour by lack of cytoplasmic Reinkes’ crystals as well as from other neoplasms like primary clear cell carcinoma, metastatic clear cell renal cell carcinoma and adrenocortical tumour.
Figures and tables
References
- Cooray SM, Bulugahapitiya UD, Samarasinghe K. Steroid cell tumor not otherwise specified of bilateral ovaries: A rare cause of post menopausal virilization. Indian J Endocrinol Metab. 2013; 17:S262-4.
- Young RH, Shully RE. Obstetric and Gynecological Pathology. Churchill Livingstone: Spain; 2003.
- Al-Farsi A, Al-Talib A.. Steroid cell tumor. Sultan Qaboos Univ Med J. 2008; 8:358-9.
- Lee J, John VS, Liang SX. Metastatic malignant ovarian steroid cell tumor: a case report and review of the literature. Case Rep Obstet Gynecol. 2016; 2016:6184573.
Affiliations
License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Copyright
© Copyright by Società Italiana di Anatomia Patologica e Citopatologia Diagnostica, Divisione Italiana della International Academy of Pathology , 2018
How to Cite
- Abstract viewed - 1020 times
- PDF downloaded - 531 times